ONCY
Oncolytics Biotech·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ONCY Filings
Filing Date
Form Description
Form Type
2025-11-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-11-12 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-04
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-04 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-28
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-28 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-20
Form F-4 - Registration of securities, foreign private issuers, business combinations
2025-10-20 ·
Form F-4 - Registration of securities, foreign private issuers, business combinations
2025-10-17
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-17 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
